Precirix
Brussels
About Precirix
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $130.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2022)
- Website: precirix.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/precirix-84217 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.